MC-RAN-8C

MC-RAN-8C

 11G x 3.5“ (9cm) with 8G x 4“ Trephine Needle

Did you know?

Harvesting intact cancellous bone cores without disrupting highly vascularized and organized tissue is superior to transplanting small pieces of morselized bone.

See Our Product CatalogSee Our BMA BrochureSee Marrow Cellution Brochure

The Marrow Cellution™ Bone Marrow Aspiration- & Autologous Bone Harvesting System (MC Ran 11C) allows physicians to combine high quality bone marrow aspirate and percutaneously harvested cancellous bone autograft dowels through a  single device in a minimally invasive manner; therefore, the morbidity of the procedure is lessened without sacrificing the cellular quality of the graft.

The highly-organized living tissue is superior to transplanting Intact Bone Cores vs. Morselized Bone

  • Harvesting intact cancelleous bone cores without disrupting pieces of bone. Intact grafts maintain the micro-vascular network within the graft promoting bone callus formation/remodeling and do not exhibit extensive resorption.¹ ²
  • Intact bone exploits the biology of normal fracture healing rather than through slow creeping substitution associated with the slow incorporation of a non-vascularized graft.¹
  • Research demonstrates the enhanced survival of a bone graft as long as its primary blood supply is preserved. A living bone graft will shorten the time for boney union because the reconstructed bone is comparable to a bone with a double fracture. ¹ ²
  • Allogenic or synthetic bone chips hydrated with marrow can be packed around the living bone graft/core to accelerate anastomosis into the graft and minimize morbidity.¹ ²

 

Minimally Invasive Bone Grafts

  • Vascularized and cancellous autograft shows optimal skeletal incorporation but is limited by morbidity concerns.³
  • Using the Marrow Cellution™ Graft Delivery Syringe and the Marrow Cellution™ Bone Core Harvest Device, the clinician can create a combination graft of a vascularized intact bone core in the center of the graft surrounded by allogeneic, autologous or synthetic bone chips hydrated with cellular marrow aspirate.
  • Higher quality, less quantity, delivered appropriately minimizes host morbidity.

 

Min.

Invasive

FDA

Cleared